| J9271 | Injection, pembrolizumab, 1 mg | 9,400 | $40 | $404.2K |
| J0897 | Injection, denosumab, 1 mg | 7,140 | $20 | $135.7K |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | 4,220 | $30 | $105.6K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 60,000 | $1 | $60K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 440 | $110 | $46.5K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 510 | $70 | $36K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 290 | $120 | $34.1K |
| Q5111 | Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg | 240 | $110 | $25.4K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 120 | $150 | $18.2K |
| 99223 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 90 | $150 | $13.2K |